Trial Profile
A randomised controlled trial of inhaled budesonide [Pulmicort turbohaler]and effector gene expression in humans
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 11 Aug 2015
Price :
$35
*
At a glance
- Drugs Budesonide (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 11 Aug 2015 New trial record